Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of fluorescent methods for DNA methyltransferase assay.

Methods and applications in fluorescence·2017
Same author

Waist-hip Ratio (WHR), a Better Predictor for Prostate Cancer than Body Mass Index (BMI): Results from a Chinese Hospital-based Biopsy Cohort.

Scientific reports·2017
Same author

Chronic nicotine differentially affects murine transcriptome profiling in isolated cortical interneurons and pyramidal neurons.

BMC genomics·2017
Same author

Combinatorial Strategy to Identify Fluorescent Probes for Biothiol and Thiophenol Based on Diversified Pyrimidine Moieties and Their Biological Applications.

Analytical chemistry·2017
Same author

Highly Specific and Ultrasensitive Two-Photon Fluorescence Imaging of Native HOCl in Lysosomes and Tissues Based on Thiocarbamate Derivatives.

Analytical chemistry·2017
Same author

Fluorescence Imaging of Intracellular Telomerase Activity Using Enzyme-Free Signal Amplification.

Analytical chemistry·2017

Related Experiment Video

Updated: Jul 13, 2026

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

24.9K

Doxorubicin prodrug for γ-glutamyl transpeptidase imaging and on-demand cancer therapy.

Yanhua Li1, Jiexiang Zhao1, Kun Tang1

  • 1College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan, 250014, PR China.

Biosensors & Bioelectronics
|January 8, 2025
PubMed
Summary

This study developed a novel doxorubicin (Dox) prodrug that targets liver cancer by responding to γ-glutamyl transpeptidase (γ-GGT). This approach enables integrated diagnosis and treatment, improving chemotherapy safety and efficacy.

Keywords:
Cancer therapyImagingLiver cancerOn-demandγ-glutamyl transpeptidase

More Related Videos

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

8.4K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.4K

Related Experiment Videos

Last Updated: Jul 13, 2026

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
08:26

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer

Published on: March 24, 2013

24.9K
Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

8.4K
Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
09:06

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression

Published on: February 3, 2023

1.4K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Drug Delivery

Background:

  • γ-glutamyl transpeptidase (γ-GGT) is a key biomarker for liver cancer progression.
  • Targeted drug delivery systems are crucial for enhancing chemotherapy efficacy and reducing side effects.
  • Developing responsive prodrugs offers a strategy for on-demand cancer treatment.

Purpose of the Study:

  • To design and synthesize a doxorubicin (Dox) prodrug responsive to γ-GGT for liver cancer imaging and treatment.
  • To create a nano-prodrug by encapsulating the Dox prodrug in hyaluronic acid-modified liposomes for enhanced tumor targeting.
  • To evaluate the efficacy of the nano-prodrug, in combination with anti-PD-L1 therapy, in inhibiting tumor growth.

Main Methods:

  • Synthesis of a γ-GGT-cleavable doxorubicin prodrug.
  • Formulation of hyaluronic acid-modified liposome nanoparticles encapsulating the doxorubicin prodrug (nano-prodrug).
  • In vitro and in vivo evaluation of the nano-prodrug's targeting ability, drug release profile, and anti-tumor efficacy, including combination therapy with anti-PD-L1.

Main Results:

  • The γ-GGT-responsive doxorubicin prodrug successfully released free doxorubicin in the presence of γ-GGT.
  • The nano-prodrug exhibited enhanced accumulation in tumors due to CD44 receptor targeting.
  • Combination therapy with anti-PD-L1 significantly inhibited both proximal and distal tumor growth, demonstrating synergistic effects.

Conclusions:

  • The developed γ-GGT-responsive nano-prodrug offers a promising strategy for targeted liver cancer therapy.
  • This integrated approach allows for imaging of γ-GGT levels and on-demand drug release, improving treatment precision.
  • The combination with anti-PD-L1 immunotherapy enhances anti-tumor activity, highlighting its potential in clinical applications.